Biomedical Engineering Reference
In-Depth Information
13. Harisinghani MG, Barentsz J, Hahn PF, Deserno WM, Tabatabaei S, van de Kaa CH, de la RJ,
Weissleder R (2003) Noninvasive detection of clinically occult lymph-node metastases in
prostate cancer. N Engl J Med 348:2491-2499
14. Josephson L, Tung C-H, Moore A, Weissleder R (1999) High-efficiency intracellular magnetic
labeling with novel superparamagnetic-tat peptide conjugates. Bioconjug Chem 10:186-191
15. Kim DH, Rossi JJ (2007) Strategies for silencing human disease using RNA interference. Nat
Rev Genet 8:173-184
16. Kumar M, Medarova Z, Pantazopoulos P, Dai G, Moore A (2010) Novel membrane-permeable
contrast agent for brain tumor detection by MRI. Magn Reson Med 63:617-624
17. Kumar M, Yigit M, Dai G, Moore A, Medarova Z (2010) Image-guided breast tumor therapy
using a small interfering RNA nanodrug. Cancer Res 70:7553-7561
18. Laurent S, Dutz S, Hafeli UO, Mahmoudi M (2011) Magnetic fluid hyperthermia: focus on
superparamagnetic iron oxide nanoparticles. Adv Colloid Interface Sci 166:8-23
19. Maier-Hauff K, Ulrich F, Nestler D, Niehoff H, Wust P, Thiesen B, Orawa H, Budach V,
Jordan A (2011) Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide
nanoparticles combined with external beam radiotherapy on patients with recurrent glioblas-
toma multiforme. J Neurooncol 103:317-324
20. Medarova Z, Evgenov NV, Dai G, Bonner-Weir S, Moore A (2006) In vivo multimodal
imaging of transplanted pancreatic islets. Nat Protoc 1:429-435
21. Medarova Z, Pham W, Farrar C, Petkova V, Moore A (2007) In-vivo imaging of siRNA
delivery and silencing in tumors. Nat Med 13:372-377
22. Medarova Z, Rashkovetsky L, Pantazopoulos P, Moore A (2009) Multiparametric monitoring
of tumor response to chemotherapy by noninvasive imaging. Cancer Res 69:1182-1189
23. Moore A, Medarova Z, Potthast A, Dai G (2004) In vivo targeting of underglycosylated MUC-
1 tumor antigen using a multimodal imaging probe. Cancer Res 64:1821-1827
24. Mouli SK, Zhao LC, Omary RA, Thaxton CS (2010) Lymphotropic nanoparticle enhanced
MRI for the staging of genitourinary tumors. Nat Rev Urol 7:84-93
25. Perez JM, Simeone FJ, Saeki Y, Josephson L, Weissleder R (2003) Viral-induced self-
assembly of magnetic nanoparticles allows the detection of viral particles in biological
media. J Am Chem Soc 125:10192-10193
26. Pittet MJ, Swirski FK, Reynolds F, Josephson L, Weissleder R (2006) Labeling of immune
cells for in vivo imaging using magnetofluorescent nanoparticles. Nat Protoc 1:73-79
27. Qian X, Peng XH, Ansari DO, Yin-Goen Q, Chen GZ, Shin DM, Yang L, Young AN, Wang
MD, Nie S (2008) In vivo tumor targeting and spectroscopic detection with surface-enhanced
Raman nanoparticle tags. Nat Biotechnol 26:83-90
28. Sjogren CE, Briley-Saebo K, Hanson M, Johansson C (1994) Magnetic characterization of iron
oxides for magnetic resonance imaging. Magn Reson Med 31:268-272
29. Storm G, Belliot SO, Daemen T, Lasic DD (1995) Surface modification of nanoparticles to
oppose uptake by the mononuclear phagocyte system. Adv Drug Deliver Rev 17:31-48
30. Torchilin VP, Trubetskoy VS (1995) Which polymers can make nanoparticulate drug carriers
long-circulating? Adv Drug Deliver Rev 16:141-155
31. Wang P, Yigit MV, Medarova Z, Wei L, Dai G, Schuetz C, Moore A (2011) Combined small
interfering RNA therapy and in vivo magnetic resonance imaging in islet transplantation.
Diabetes 60:565-571
32. Weissleder R, Moore A, Mahmood U, Bhorade R, Benveniste H, Chiocca EA, Basilion JP
(2000) In vivo magnetic resonance imaging of transgene expression. Nat Med 6:351-354
33. Yigit MV, Mazumdar D, Kim HK, Lee JH, Odintsov B, Lu Y (2007) Smart “turn-on” magnetic
resonance contrast agents based on aptamer-functionalized superparamagnetic iron oxide
nanoparticles. Chembiochem 8:1675-1678
34. Yigit MV, Mazumdar D, Lu Y (2008) MRI detection of thrombin with aptamer functionalized
superparamagnetic iron oxide nanoparticles. Bioconjug Chem 19:412-417
Search WWH ::
Custom Search